CEDRUS’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,476
Closed -$283K 152
2023
Q1
$283K Sell
1,476
-4
-0.3% -$723 0.2% 127
2022
Q4
$249K Buy
1,480
+4
+0.3% +$695 0.2% 126
2022
Q3
$261K Buy
1,476
+11
+0.8% +$2.17K 0.25% 86
2022
Q2
$300K Buy
1,465
+137
+10% +$29K 0.29% 77
2022
Q1
$316K Buy
1,328
+129
+11% +$30.3K 0.28% 92
2021
Q4
$274K Buy
+1,199
New +$264K 0.26% 111

Other funds holding CME

CEDRUS's CME Position: Q2 2023 in Review

CEDRUS sold out of CME Group (CME) in Q2 2023, closing a stake of 1,476 shares — an estimated $283K sold.

CEDRUS first reported a position in CME in Q4 2021 and held it in 6 quarters. The position peaked at $316K in Q1 2022. 1,193 funds tracked by Wall St. Rank hold CME as of Q2 2023.

  • CEDRUS reported no remaining CME Group position as of Q2 2023 after selling out during the quarter.
  • CEDRUS sold 1,476 CME Group shares in Q2 2023, an estimated $283K.
  • CEDRUS first reported a position in CME Group in Q4 2021 and held it in 6 quarters.
  • CEDRUS's CME Group position peaked at $316K in Q1 2022.
  • 1,193 funds tracked by Wall St. Rank held CME Group as of Q2 2023.

Based on CEDRUS's 13F filing for Q2 2023, filed 24 Jan 2024.